Assignee
COMPUGEN LTD
IL·50 granted patents·66 pending applications·967 citations·filing 1998–2025
Top patents by PatentIndex Score
116 records- 0198US7368548B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancerCOMPUGEN LTD·Filed 2005·Granted May 6, 2008·83 cites·4 claims
- 0297US7569662B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2005·Granted Aug 4, 2009·73 cites·3 claims
- 0396US7667001B1Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2007·Granted Feb 23, 2010·75 cites·9 claims
- 0495US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0595US7655781B2Variants of human glycoprotein hormone alpha chain: compositions and uses thereofCOMPUGEN LTD·Filed 2006·Granted Feb 2, 2010·27 cites·10 claims
- 0694US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0794US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 0893US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 0993US7745391B2Human thrombospondin polypeptideCOMPUGEN LTD·Filed 2006·Granted Jun 29, 2010·455 cites·2 claims
- 1093US7332569B2Brain natriuretic peptide spliced variantCOMPUGEN LTD·Filed 2005·Granted Feb 19, 2008·26 cites·1 claims
- 1192US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 1292US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 1391US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 1490US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 1590US7741433B2Diagnostic markers, especially for in vivo imaging and assays and methods of use thereofCOMPUGEN LTD·Filed 2007·Granted Jun 22, 2010·7 cites·16 claims
- 1690US7345142B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2005·Granted Mar 18, 2008·16 cites·8 claims
- 1789US7488813B2Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereofCOMPUGEN LTD·Filed 2006·Granted Feb 10, 2009·12 cites·2 claims
- 1887US11225523B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2018·Granted Jan 18, 2022·3 cites·11 claims
- 1987US7842459B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2005·Granted Nov 30, 2010·7 cites·5 claims
- 2086US7939634B2Polynucleotides encoding polypeptides and methods using sameCOMPUGEN LTD·Filed 2005·Granted May 10, 2011·9 cites·5 claims
- 2186US7714100B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2007·Granted May 11, 2010·3 cites·6 claims
- 2285US12558421B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Granted Feb 24, 2026·0 cites·10 claims
- 2385US6740516B2Nucleic acid and amino acid sequencesCOMPUGEN LTD·Filed 2001·Granted May 25, 2004·21 cites·6 claims
- 2484US9617336B2C10RF32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Granted Apr 11, 2017·14 cites·23 claims
- 2584US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 2684US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 2783US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 2882US7884180B2Peptides which bind to G protein-coupled receptorsCOMPUGEN LTD·Filed 2007·Granted Feb 8, 2011·4 cites·16 claims
- 2982US7553948B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2007·Granted Jun 30, 2009·6 cites·5 claims
- 3081US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 3181US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 3280US2025136710A1Triple combination antibody therapiesCOMPUGEN LTD·Filed 2024·Application pending·0 cites
- 3379US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 3478US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 3578US8349801B2Peptide ligands for G-protein coupled receptorsCOMPUGEN LTD·Filed 2007·Granted Jan 8, 2013·2 cites·12 claims
- 3678US7678769B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2007·Granted Mar 16, 2010·1 cites·6 claims
- 3778US6783954B2VEGF nucleic acid and amino acid sequencesCOMPUGEN LTD·Filed 2001·Granted Aug 31, 2004·7 cites·8 claims
- 3876US6936450B2Variants of protein kinasesCOMPUGEN LTD·Filed 2001·Granted Aug 30, 2005·5 cites·3 claims
- 3975US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 4075US6506884B1Variant of vascular endothelial growth factorCOMPUGEN LTD·Filed 2000·Granted Jan 14, 2003·6 cites·6 claims
- 4175US2022048972A1Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerCOMPUGEN LTD·Filed 2021·Application pending·0 cites
- 4274US12152084B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2021·Granted Nov 26, 2024·0 cites·12 claims
- 4374US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 4473US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 4573US7758862B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2006·Granted Jul 20, 2010·2 cites·16 claims
- 4673US7601692B2MCP-1 splice variants and methods of using sameCOMPUGEN LTD·Filed 2006·Granted Oct 13, 2009·2 cites·4 claims
- 4772US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 4870US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 4970US7906635B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2009·Granted Mar 15, 2011·2 cites·8 claims
- 5070US2010248270A1Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac DiseaseCOMPUGEN LTD·Filed 2009·Application pending·0 cites
Showing the top 50 of 116 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →